Ortoton

• Film-coated tablets:

• 500 mg

• 750 mg

• 1500 mg

• Injection solution

The medication is used to treat painful muscle spasms associated with:

• Diseases and injuries of the musculoskeletal system

• Part of the combination therapy for tetanus

• Tablets:

• The optimal dosage for adults is 750 mg (two tablets), three times daily.

• It is important to maintain regular dosing intervals to ensure stable therapeutic effects.

• The duration of treatment is determined individually but should not exceed 30 days.

• If symptoms persist, a consultation with a physician is necessary to adjust the therapy if required.

• Injection Solution:

• The dosage and method of administration are determined by a physician.

• Hypersensitivity to Methocarbamol or excipients

• Severe hepatic or renal insufficiency

• Myasthenia gravis

• Predisposition to epileptic seizures

• Use with caution in patients with liver or kidney diseases.

• Avoid alcohol consumption during treatment.

Enhances the effects of sedatives, antidepressants, and other central nervous system (CNS) depressants.

• Use is permitted only under strict medical indication and supervision.

• Not recommended during breastfeeding.

• May cause drowsiness and dizziness, reducing alertness.

• Avoid driving or operating machinery while under treatment.

• Common (≥1/100, <1/10): Dizziness, drowsiness, nausea

• Rare (≥1/10000, <1/1000): Allergic reactions

• Symptoms: CNS depression, intensification of side effects

• Treatment: Symptomatic therapy under medical supervision

• Methocarbamol produces a muscle-relaxing effect by reducing skeletal muscle tone.

• It also blocks the action of endothelin, an endogenous vasoconstrictor peptide.

• Rapidly absorbed when taken orally

• Metabolized in the liver

• Eliminated through the kidneys

Centrally acting muscle relaxants

• Stearic Acid

• Magnesium Stearate

• Hypromellose

• Sodium Starch Glycolate Type A

• Povidone K25

• Sodium Lauryl Sulfate

• Corn Starch

• Lactose Monohydrate

• Macrogol 4000

• Titanium Dioxide

• May enhance the effects of sedative and muscle-relaxing drugs.

3 years from the production date (as specified on the packaging).

• Store at temperatures up to 25°C.

• Keep in a dry, light-protected place.

• Keep out of reach of children.

• Tablets: Blister packs of 10–20 tablets

• Injection Solution: Ampoules of 1–2 ml

Dispose of in accordance with local regulations for medical waste.

Officially registered in EU countries, the United States, and certain Asian countries (also sold under trade names such as Robaxin).

• Recordati Pharma GmbH (Germany)

• Xanodyne Pharmaceuticals (USA)

• Caraco Pharmaceutical (USA)

• Tablets: Prescription-only in the US and EU (Rx); in Canada, available over the counter in low doses.

• Injection Solution: Prescription-only, with specified dosage and administration details.

• Prolonged use without medical supervision is not recommended.

• This information is intended for use by healthcare professionals only.

• All data should be verified using the official package insert.

M03BA03 Methocarbamol

• A35 – Other tetanus forms

• R25.3 – Fasciculation

• R52.9 – Unspecified pain